Ranbaxy resumes supply of Atorvastatin tablets to US market

Ranbaxy Pharmaceuticals Inc, the US subsidiary of Ranbaxy Laboratories has resumed the supply of Atorvastatin tablets to the US market.

April 01, 2013 / 16:32 IST

Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated April 01, 2013, titled "Ranbaxy resumes the supply of Atorvastatin tablets to the US market". Ranbaxy Pharmaceuticals Inc, the US subsidiary of Ranbaxy Laboratories has resumed the supply of Atorvastatin tablets to the US market.Source : BSE

Read all announcements in Ranbaxy Labs

first published: Apr 1, 2013 04:32 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Ranbaxy resumes supply of Atorvastatin tablets to US market

Ranbaxy Pharmaceuticals Inc, the US subsidiary of Ranbaxy Laboratories has resumed the supply of Atorvastatin tablets to the US market.

RL